Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Nierengarten's Stock Ratings
Wedbush Analyst
David Nierengarten is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
18.3%
Smart Score
Overall Average Return Percentile
74th
Number of Ratings
335
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/11/2025 | BBOT | Buy Now | BridgeBio Oncology | $12.19 | 105.09% | $25 → $25 | Reiterates | Outperform → Outperform | Get Alert | |
| 12/08/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.41 | 112.54% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/25/2025 | BBOT | Buy Now | BridgeBio Oncology | $12.19 | 105.09% | $25 → $25 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/14/2025 | ARGX | Buy Now | argenx | $851.59 | 17.43% | $880 → $1000 | Maintains | Outperform | Get Alert | |
| 11/07/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | -23.83% | $9 → $7 | Maintains | Neutral | Get Alert | |
| 10/27/2025 | FATE | Buy Now | Fate Therapeutics | $1.14 | 516.74% | $5 → $7 | Upgrade | Neutral → Outperform | Get Alert | |
| 10/17/2025 | IRON | Buy Now | Disc Medicine | $91.45 | 20.28% | $90 → $110 | Maintains | Outperform | Get Alert | |
| 10/15/2025 | ANAB | Buy Now | AnaptysBio | $45.09 | 55.25% | $45 → $70 | Maintains | Outperform | Get Alert | |
| 10/13/2025 | ARGX | Buy Now | argenx | $851.59 | 3.34% | $800 → $880 | Maintains | Outperform | Get Alert | |
| 10/13/2025 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $41.63 | 5.68% | $38 → $44 | Maintains | Outperform | Get Alert | |
| 10/13/2025 | NUVB | Buy Now | Nuvation Bio | $8.45 | -28.99% | $6 → $6 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/08/2025 | NUVB | Buy Now | Nuvation Bio | $8.45 | -28.99% | $6 → $6 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/08/2025 | NUVL | Buy Now | Nuvalent | $104.26 | 10.3% | $115 → $115 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/08/2025 | STTK | Buy Now | Shattuck Labs | $2.91 | 37.46% | → $4 | Initiates | → Outperform | Get Alert | |
| 09/02/2025 | XNCR | Buy Now | Xencor | $16.84 | 54.35% | $26 → $26 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/28/2025 | TLX | Buy Now | Telix Pharmaceuticals | $8.67 | 153.75% | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/18/2025 | BBOT | Buy Now | BridgeBio Oncology | $12.19 | 105.09% | → $25 | Initiates | → Outperform | Get Alert | |
| 08/13/2025 | GBIO | Buy Now | Generation Bio | $5.41 | 29.39% | $7 → $7 | Downgrade | Outperform → Neutral | Get Alert | |
| 08/07/2025 | XNCR | Buy Now | Xencor | $16.84 | 54.35% | $31 → $26 | Maintains | Outperform | Get Alert | |
| 07/25/2025 | IKNA | Buy Now | Ikena Oncology | — | — | $25 → $23 | Maintains | Neutral | Get Alert | |
| 06/26/2025 | VOR | Buy Now | Vor Biopharma | $13.32 | -97% | $0.4 → $0.4 | Reiterates | Neutral → Neutral | Get Alert | |
| 06/24/2025 | ARGX | Buy Now | argenx | $851.59 | -16.04% | $715 → $715 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/23/2025 | CATX | Buy Now | Perspective Therapeutics | $2.73 | 302.19% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/12/2025 | TLX | Buy Now | Telix Pharmaceuticals | $8.67 | 153.75% | $22 → $22 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/11/2025 | NUVB | Buy Now | Nuvation Bio | $8.45 | -40.83% | $5 → $5 | Maintains | Outperform | Get Alert | |
| 06/11/2025 | ARGX | Buy Now | argenx | $851.59 | -16.04% | $715 → $715 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/05/2025 | TLX | Buy Now | Telix Pharmaceuticals | $8.67 | 153.75% | → $22 | Initiates | → Outperform | Get Alert | |
| 06/02/2025 | BPMC | Buy Now | Blueprint Medicines | — | — | $128 → $129 | Downgrade | Outperform → Neutral | Get Alert | |
| 05/28/2025 | ITOS | Buy Now | ITeos Therapeutics | — | — | $10 → $12 | Downgrade | Outperform → Neutral | Get Alert | |
| 05/19/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | 8.81% | $10 → $10 | Reiterates | Neutral → Neutral | Get Alert | |
| 05/16/2025 | NUVB | Buy Now | Nuvation Bio | $8.45 | -40.83% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/16/2025 | NVCR | Buy Now | NovoCure | $13.20 | 104.59% | $29 → $27 | Maintains | Neutral | Get Alert | |
| 04/16/2025 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $41.63 | -18.34% | $34 → $34 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/16/2025 | ARGX | Buy Now | argenx | $851.59 | -16.04% | $715 → $715 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/16/2025 | BPMC | Buy Now | Blueprint Medicines | — | — | $128 → $128 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/11/2025 | ARGX | Buy Now | argenx | $851.59 | -16.04% | $715 → $715 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/27/2025 | CATX | Buy Now | Perspective Therapeutics | $2.73 | 302.19% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/20/2025 | IMNM | Buy Now | Immunome | $24.26 | 36.03% | $33 → $33 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/14/2025 | STRO | Buy Now | Sutro Biopharma | $9.76 | -79.51% | $8 → $2 | Downgrade | Outperform → Neutral | Get Alert | |
| 03/06/2025 | FATE | Buy Now | Fate Therapeutics | $1.14 | 340.53% | $5 → $5 | Reiterates | Neutral → Neutral | Get Alert | |
| 02/12/2025 | BCAX | Buy Now | Bicara Therapeutics | $18.40 | 68.48% | $31 → $31 | Reiterates | Outperform → Outperform | Get Alert | |
| 02/12/2025 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $77 → $77 | Reiterates | Outperform → Outperform | Get Alert | |
| 02/07/2025 | ANAB | Buy Now | AnaptysBio | $45.09 | -11.29% | $40 → $40 | Maintains | Outperform | Get Alert | |
| 02/06/2025 | BCAX | Buy Now | Bicara Therapeutics | $18.40 | 68.48% | → $31 | Initiates | → Outperform | Get Alert | |
| 01/13/2025 | BPMC | Buy Now | Blueprint Medicines | — | — | $135 → $124 | Reiterates | Outperform → Outperform | Get Alert | |
| 12/02/2024 | APGE | Buy Now | Apogee Therapeutics | $76.92 | 17% | $87 → $90 | Maintains | Outperform | Get Alert | |
| 11/25/2024 | SRRK | Buy Now | Scholar Rock Holding | $44.88 | 4.71% | $40 → $47 | Maintains | Outperform | Get Alert | |
| 11/18/2024 | CMRX | Buy Now | Chimerix | — | — | $6 → $6 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/18/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | 52.34% | $14 → $14 | Reiterates | Neutral → Neutral | Get Alert | |
| 10/25/2024 | APGE | Buy Now | Apogee Therapeutics | $76.92 | 13.1% | $87 → $87 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/25/2024 | IMNM | Buy Now | Immunome | $24.26 | 36.03% | $33 → $33 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/24/2024 | CATX | Buy Now | Perspective Therapeutics | $2.73 | 631.26% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/22/2024 | NUVB | Buy Now | Nuvation Bio | $8.45 | -40.83% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/07/2024 | SRRK | Buy Now | Scholar Rock Holding | $44.88 | -17.57% | $27 → $37 | Maintains | Outperform | Get Alert | |
| 10/01/2024 | CATX | Buy Now | Perspective Therapeutics | $2.73 | 814.08% | → $25 | Initiates | → Outperform | Get Alert | |
| 09/30/2024 | INZY | Buy Now | Inozyme Pharma | — | — | $15 → $15 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/26/2024 | ANAB | Buy Now | AnaptysBio | $45.09 | -6.85% | $42 → $42 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/16/2024 | NUVL | Buy Now | Nuvalent | $104.26 | 10.3% | $99 → $115 | Maintains | Outperform | Get Alert | |
| 09/11/2024 | NUVB | Buy Now | Nuvation Bio | $8.45 | -40.83% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/10/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $23 → $23 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/10/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.41 | 112.54% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/09/2024 | NUVL | Buy Now | Nuvalent | $104.26 | -5.04% | $99 → $99 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/04/2024 | ORKA | Buy Now | Oruka Therapeutics | $30.77 | 30% | → $40 | Initiates | → Outperform | Get Alert | |
| 09/04/2024 | SYRE | Buy Now | Spyre Therapeutics | $34.24 | 31.43% | → $45 | Initiates | → Outperform | Get Alert | |
| 08/13/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.41 | 112.54% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/13/2024 | TCRX | Buy Now | TScan Therapeutics | $1.00 | 902.41% | $10 → $10 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/13/2024 | IMNM | Buy Now | Immunome | $24.26 | 36.03% | $33 → $33 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/13/2024 | ARTV | Buy Now | Artiva Biotherapeutics | $5.22 | 244.83% | → $18 | Initiates | → Outperform | Get Alert | |
| 08/09/2024 | IRON | Buy Now | Disc Medicine | $91.45 | -37.67% | $57 → $57 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/08/2024 | GBIO | Buy Now | Generation Bio | $5.41 | -7.58% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/26/2024 | INZY | Buy Now | Inozyme Pharma | — | — | $15 → $15 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/26/2024 | ARGX | Buy Now | argenx | $851.59 | -34.24% | $519 → $560 | Maintains | Outperform | Get Alert | |
| 07/23/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $41.63 | -18.34% | $30 → $34 | Maintains | Outperform | Get Alert | |
| 07/22/2024 | ARGX | Buy Now | argenx | $851.59 | -39.05% | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/17/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.41 | 112.54% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/17/2024 | ARGX | Buy Now | argenx | $851.59 | -39.05% | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/01/2024 | ARGX | Buy Now | argenx | $851.59 | -39.05% | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/27/2024 | TSVT | Buy Now | 2seventy bio | — | — | $5 → $5 | Reiterates | Neutral → Neutral | Get Alert | |
| 06/26/2024 | ARGX | Buy Now | argenx | $851.59 | -39.05% | $519 → $519 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/29/2024 | IKNA | Buy Now | Ikena Oncology | — | — | $8 → $2 | Downgrade | Outperform → Neutral | Get Alert | |
| 05/24/2024 | COGT | Buy Now | Cogent Biosciences | $40.77 | -75.48% | $10 → $10 | Reiterates | Neutral → Neutral | Get Alert | |
| 05/24/2024 | NUVB | Buy Now | Nuvation Bio | $8.45 | -40.83% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/17/2024 | NUVL | Buy Now | Nuvalent | $104.26 | -5.04% | $99 → $99 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/15/2024 | NUVB | Buy Now | Nuvation Bio | $8.45 | -40.83% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/14/2024 | STRO | Buy Now | Sutro Biopharma | $9.76 | -18.03% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/14/2024 | IKNA | Buy Now | Ikena Oncology | — | — | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/14/2024 | GBIO | Buy Now | Generation Bio | $5.41 | -7.58% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/10/2024 | VOR | Buy Now | Vor Biopharma | $13.32 | -17.43% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/10/2024 | ANAB | Buy Now | AnaptysBio | $45.09 | -24.6% | → $34 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/10/2024 | XNCR | Buy Now | Xencor | $16.84 | 113.71% | $34 → $36 | Maintains | Outperform | Get Alert | |
| 05/10/2024 | FATE | Buy Now | Fate Therapeutics | $1.14 | 340.53% | $7 → $5 | Maintains | Neutral | Get Alert | |
| 05/06/2024 | FATE | Buy Now | Fate Therapeutics | $1.14 | 516.74% | $7 → $7 | Reiterates | Neutral → Neutral | Get Alert | |
| 04/26/2024 | BPMC | Buy Now | Blueprint Medicines | — | — | $110 → $110 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/23/2024 | BEAM | Buy Now | Beam Therapeutics | $27.55 | 106.9% | $57 → $57 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/23/2024 | VOR | Buy Now | Vor Biopharma | $13.32 | -17.43% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/23/2024 | TCRX | Buy Now | TScan Therapeutics | $1.00 | 902.41% | $10 → $10 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/23/2024 | PRME | Buy Now | Prime Medicine | $4.15 | 189.16% | $12 → $12 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/23/2024 | FATE | Buy Now | Fate Therapeutics | $1.14 | 516.74% | $7 → $7 | Reiterates | Neutral → Neutral | Get Alert | |
| 04/23/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | 215.56% | $29 → $29 | Reiterates | Neutral → Neutral | Get Alert | |
| 04/18/2024 | ARGX | Buy Now | argenx | $851.59 | -38.82% | $521 → $521 | Reiterates | Outperform → Outperform | Get Alert | |
| 04/03/2024 | PRME | Buy Now | Prime Medicine | $4.15 | 189.16% | → $12 | Initiates | → Outperform | Get Alert | |
| 04/02/2024 | PRME | Buy Now | Prime Medicine | $4.15 | 189.16% | → $12 | Initiates | → Outperform | Get Alert | |
| 04/01/2024 | IMNM | Buy Now | Immunome | $24.26 | 36.03% | $27 → $33 | Maintains | Outperform | Get Alert | |
| 03/26/2024 | STRO | Buy Now | Sutro Biopharma | $9.76 | -18.03% | $12 → $8 | Maintains | Outperform | Get Alert | |
| 03/21/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | $24 → $24 | Reiterates | Neutral → Neutral | Get Alert | |
| 03/21/2024 | VOR | Buy Now | Vor Biopharma | $13.32 | -17.43% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/19/2024 | BLUE | Buy Now | bluebird bio | — | — | $3 → $1.68 | Maintains | Neutral | Get Alert | |
| 03/19/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $24 | Downgrade | Outperform → Neutral | Get Alert | |
| 03/18/2024 | TSVT | Buy Now | 2seventy bio | — | — | $5 → $5 | Reiterates | Neutral → Neutral | Get Alert | |
| 03/12/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.41 | 112.54% | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/12/2024 | ANAB | Buy Now | AnaptysBio | $45.09 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 03/07/2024 | GBIO | Buy Now | Generation Bio | $5.41 | -7.58% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/01/2024 | NUVB | Buy Now | Nuvation Bio | $8.45 | -40.83% | $5 → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/01/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.41 | 112.54% | $12 → $20 | Maintains | Outperform | Get Alert | |
| 02/29/2024 | MRSN | Buy Now | Mersana Therapeutics | $28.51 | -75.45% | $2 → $7 | Upgrade | Neutral → Outperform | Get Alert | |
| 02/28/2024 | XNCR | Buy Now | Xencor | $16.84 | 101.84% | $36 → $34 | Maintains | Outperform | Get Alert | |
| 02/27/2024 | FATE | Buy Now | Fate Therapeutics | $1.14 | 516.74% | $3 → $7 | Maintains | Neutral | Get Alert | |
| 02/26/2024 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $60 → $70 | Maintains | Outperform | Get Alert | |
| 02/23/2024 | COGT | Buy Now | Cogent Biosciences | $40.77 | -75.48% | $5 → $10 | Maintains | Neutral | Get Alert | |
| 02/13/2024 | GTHX | Buy Now | G1 Therapeutics | — | — | $5 → $4 | Maintains | Outperform | Get Alert | |
| 02/01/2024 | TCRX | Buy Now | TScan Therapeutics | $1.00 | 802.17% | $9 → $9 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/30/2024 | INZY | Buy Now | Inozyme Pharma | — | — | $15 → $15 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/26/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | $13 → $13 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/23/2024 | IMNM | Buy Now | Immunome | $24.26 | -21.68% | $12 → $19 | Maintains | Outperform | Get Alert | |
| 01/19/2024 | IKNA | Buy Now | Ikena Oncology | — | — | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/18/2024 | VOR | Buy Now | Vor Biopharma | $13.32 | -17.43% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/17/2024 | KNTE | Buy Now | Kinnate Biopharma | — | — | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert | |
| 01/02/2024 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $41.63 | -39.95% | $23 → $25 | Maintains | Outperform | Get Alert | |
| 12/19/2023 | IMNM | Buy Now | Immunome | $24.26 | -50.54% | → $12 | Initiates | → Outperform | Get Alert | |
| 12/11/2023 | COGT | Buy Now | Cogent Biosciences | $40.77 | -87.74% | $20 → $5 | Downgrade | Outperform → Neutral | Get Alert | |
| 12/08/2023 | MAXN | Buy Now | Maxeon Solar Technologies | $3.39 | 47.49% | $14 → $5 | Maintains | Equal-Weight | Get Alert | |
| 11/29/2023 | ANAB | Buy Now | AnaptysBio | $45.09 | -55.64% | → $20 | Reiterates | Neutral → Neutral | Get Alert | |
| 11/20/2023 | TSVT | Buy Now | 2seventy bio | — | — | → $2 | Downgrade | Outperform → Neutral | Get Alert | |
| 11/10/2023 | GBIO | Buy Now | Generation Bio | $5.41 | 66.36% | $11 → $9 | Maintains | Outperform | Get Alert | |
| 11/09/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | 215.56% | $45 → $29 | Maintains | Neutral | Get Alert | |
| 11/09/2023 | FATE | Buy Now | Fate Therapeutics | $1.14 | 164.32% | $6 → $3 | Maintains | Neutral | Get Alert | |
| 11/08/2023 | XNCR | Buy Now | Xencor | $16.84 | 113.71% | $37 → $36 | Maintains | Outperform | Get Alert | |
| 11/03/2023 | ANAB | Buy Now | AnaptysBio | $45.09 | -55.64% | $18 → $20 | Maintains | Neutral | Get Alert | |
| 10/30/2023 | GTHX | Buy Now | G1 Therapeutics | — | — | → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/23/2023 | STRO | Buy Now | Sutro Biopharma | $9.76 | 22.95% | → $12 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/23/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.41 | 48.78% | → $14 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/18/2023 | FRLN | Buy Now | Freeline Therapeutics | — | — | $8 → $5 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/18/2023 | ITOS | Buy Now | ITeos Therapeutics | — | — | → $33 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/22/2023 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.41 | 48.78% | → $14 | Initiates | → Outperform | Get Alert | |
| 09/22/2023 | IKNA | Buy Now | Ikena Oncology | — | — | → $11 | Initiates | → Outperform | Get Alert | |
| 09/19/2023 | KNTE | Buy Now | Kinnate Biopharma | — | — | $14 → $2 | Downgrade | Outperform → Neutral | Get Alert | |
| 09/08/2023 | INZY | Buy Now | Inozyme Pharma | — | — | → $15 | Maintains | Outperform | Get Alert | |
| 08/17/2023 | CMRX | Buy Now | Chimerix | — | — | → $6 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/11/2023 | STRO | Buy Now | Sutro Biopharma | $9.76 | 22.95% | $20 → $12 | Maintains | Outperform | Get Alert | |
| 08/11/2023 | VOR | Buy Now | Vor Biopharma | $13.32 | -17.43% | $18 → $11 | Maintains | Outperform | Get Alert | |
| 08/10/2023 | SRRK | Buy Now | Scholar Rock Holding | $44.88 | -46.53% | → $24 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/08/2023 | ANAB | Buy Now | AnaptysBio | $45.09 | -42.34% | $29 → $26 | Maintains | Neutral | Get Alert | |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $76.92 | -48% | → $40 | Initiates | → Outperform | Get Alert | |
| 08/03/2023 | GBIO | Buy Now | Generation Bio | $5.41 | 103.33% | → $11 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/03/2023 | GTHX | Buy Now | G1 Therapeutics | — | — | → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/28/2023 | TSVT | Buy Now | 2seventy bio | — | — | $26 → $22 | Maintains | Outperform | Get Alert | |
| 07/27/2023 | MRSN | Buy Now | Mersana Therapeutics | $28.51 | -92.98% | $12 → $2 | Downgrade | Outperform → Neutral | Get Alert | |
| 07/26/2023 | KPTI | Buy Now | Karyopharm Therapeutics | $6.80 | -41.18% | $7 → $4 | Maintains | Neutral | Get Alert | |
| 07/20/2023 | NUVL | Buy Now | Nuvalent | $104.26 | -49.16% | → $53 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/18/2023 | ARGX | Buy Now | argenx | $851.59 | -33.07% | → $570 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/14/2023 | THRX | Buy Now | Theseus Pharmaceuticals | — | — | $24 → $7 | Maintains | Outperform | Get Alert | |
| 07/13/2023 | SRRK | Buy Now | Scholar Rock Holding | $44.88 | -46.53% | → $24 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/12/2023 | AVRO | Buy Now | Avrobio | — | — | → $2 | Downgrade | Outperform → Neutral | Get Alert | |
| 06/28/2023 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $13 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/22/2023 | TCRX | Buy Now | TScan Therapeutics | $1.00 | 701.92% | → $8 | Initiates | → Outperform | Get Alert | |
| 06/21/2023 | ARGX | Buy Now | argenx | $851.59 | -46.69% | → $454 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/07/2023 | NVCR | Buy Now | NovoCure | $13.20 | 248.56% | $53 → $46 | Upgrade | Underperform → Neutral | Get Alert | |
| 05/18/2023 | TSVT | Buy Now | 2seventy bio | — | — | → $26 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/15/2023 | TSVT | Buy Now | 2seventy bio | — | — | → $26 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/12/2023 | VOR | Buy Now | Vor Biopharma | $13.32 | 35.11% | → $18 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/12/2023 | KNTE | Buy Now | Kinnate Biopharma | — | — | → $14 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/12/2023 | ANAB | Buy Now | AnaptysBio | $45.09 | -35.68% | → $29 | Reiterates | Neutral → Neutral | Get Alert | |
| 05/10/2023 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | $5 → $13 | Upgrade | Neutral → Outperform | Get Alert | |
| 05/09/2023 | XNCR | Buy Now | Xencor | $16.84 | 119.65% | $39 → $37 | Maintains | Outperform | Get Alert | |
| 05/01/2023 | ISEE | Buy Now | IVERIC bio | — | — | $35 → $40 | Downgrade | Outperform → Neutral | Get Alert | |
| 04/26/2023 | IRON | Buy Now | Disc Medicine | $91.45 | -60.63% | $32 → $36 | Maintains | Outperform | Get Alert | |
| 04/21/2023 | ARGX | Buy Now | argenx | $851.59 | -49.27% | → $432 | Reiterates | → Outperform | Get Alert | |
| 04/03/2023 | ISEE | Buy Now | IVERIC bio | — | — | → $29 | Reiterates | → Outperform | Get Alert | |
| 03/31/2023 | STRO | Buy Now | Sutro Biopharma | $9.76 | 104.92% | → $20 | Reiterates | → Outperform | Get Alert | |
| 03/17/2023 | TSVT | Buy Now | 2seventy bio | — | — | $28 → $21 | Maintains | Outperform | Get Alert | |
| 03/16/2023 | KNTE | Buy Now | Kinnate Biopharma | — | — | $29 → $25 | Maintains | Outperform | Get Alert | |
| 03/16/2023 | NUVB | Buy Now | Nuvation Bio | $8.45 | -40.83% | → $5 | Reiterates | → Outperform | Get Alert | |
| 03/16/2023 | ITOS | Buy Now | ITeos Therapeutics | — | — | $45 → $33 | Maintains | Outperform | Get Alert | |
| 02/24/2023 | GBIO | Buy Now | Generation Bio | $5.41 | 177.26% | $24 → $15 | Maintains | Outperform | Get Alert | |
| 01/26/2023 | MGTA | Buy Now | Magenta Therapeutics | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 01/18/2023 | NUVL | Buy Now | Nuvalent | $104.26 | -62.59% | → $39 | Initiates | → Outperform | Get Alert | |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $1.14 | 516.74% | → $7 | Downgrade | Outperform → Neutral | Get Alert | |
| 01/04/2023 | IRON | Buy Now | Disc Medicine | $91.45 | -67.2% | → $30 | Initiates | → Outperform | Get Alert | |
| 10/31/2022 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | → $6 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/24/2022 | AGTC | Buy Now | Applied Genetic Techs | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 09/26/2022 | FENC | Buy Now | Fennec Pharmaceuticals | $7.76 | 144.85% | $11 → $19 | Maintains | Outperform | Get Alert | |
| 09/16/2022 | GTHX | Buy Now | G1 Therapeutics | — | — | $20 → $25 | Maintains | Outperform | Get Alert | |
| 07/26/2022 | VOR | Buy Now | Vor Biopharma | $13.32 | 35.11% | → $18 | Initiates | → Outperform | Get Alert | |
| 06/27/2022 | EPZM | Buy Now | Epizyme | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 06/03/2022 | TPTX | Buy Now | Turning Point | — | — | $61 → $76 | Downgrade | Outperform → Neutral | Get Alert | |
| 05/27/2022 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $110 → $50 | Maintains | Outperform | Get Alert | |
| 03/16/2022 | INZY | Buy Now | Inozyme Pharma | — | — | $35 → $25 | Maintains | Outperform | Get Alert | |
| 02/22/2022 | CDAK | Buy Now | Codiak BioSciences | — | — | $34 → $24 | Maintains | Outperform | Get Alert | |
| 01/10/2022 | SRRK | Buy Now | Scholar Rock Holding | $44.88 | 11.4% | $66 → $50 | Maintains | Outperform | Get Alert | |
| 12/15/2021 | FATE | Buy Now | Fate Therapeutics | $1.14 | 6419.82% | $71 → $74 | Upgrade | Neutral → Outperform | Get Alert | |
| 12/14/2021 | GBIO | Buy Now | Generation Bio | $5.41 | 473.01% | $36 → $31 | Maintains | Outperform | Get Alert | |
| 11/08/2021 | TSVT | Buy Now | 2seventy bio | — | — | → $40 | Initiates | → Outperform | Get Alert | |
| 11/01/2021 | THRX | Buy Now | Theseus Pharmaceuticals | — | — | → $24 | Initiates | → Outperform | Get Alert | |
| 09/17/2021 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $45 → $11 | Downgrade | Outperform → Neutral | Get Alert | |
| 07/22/2021 | ARGX | Buy Now | argenx | $851.59 | -57.49% | $344 → $362 | Maintains | Outperform | Get Alert | |
| 07/14/2021 | GBIO | Buy Now | Generation Bio | $5.41 | 565.43% | $40 → $36 | Maintains | Outperform | Get Alert | |
| 06/29/2021 | BEAM | Buy Now | Beam Therapeutics | $27.55 | 440.83% | $114 → $149 | Maintains | Outperform | Get Alert | |
| 06/28/2021 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | 846.68% | $73 → $87 | Maintains | Neutral | Get Alert | |
| 06/08/2021 | ARGX | Buy Now | argenx | $851.59 | -59.6% | $356 → $344 | Maintains | Outperform | Get Alert | |
| 04/14/2021 | NVCR | Buy Now | NovoCure | $13.20 | 1066.93% | $159 → $154 | Downgrade | Neutral → Underperform | Get Alert | |
| 03/31/2021 | CMRX | Buy Now | Chimerix | — | — | → $14 | Initiates | → Outperform | Get Alert | |
| 03/09/2021 | ANAB | Buy Now | AnaptysBio | $45.09 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 03/08/2021 | NUVB | Buy Now | Nuvation Bio | $8.45 | 136.69% | → $20 | Initiates | → Outperform | Get Alert | |
| 02/26/2021 | FATE | Buy Now | Fate Therapeutics | $1.14 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 11/10/2020 | SRRK | Buy Now | Scholar Rock Holding | $44.88 | 4.71% | $33 → $47 | Maintains | Outperform | Get Alert | |
| 11/09/2020 | CDAK | Buy Now | Codiak BioSciences | — | — | → $19 | Initiates | → Outperform | Get Alert | |
| 10/27/2020 | SRRK | Buy Now | Scholar Rock Holding | $44.88 | -26.48% | $23 → $33 | Maintains | Outperform | Get Alert | |
| 10/27/2020 | ANAB | Buy Now | AnaptysBio | $45.09 | -22.38% | $20 → $35 | Upgrade | Neutral → Outperform | Get Alert | |
| 10/06/2020 | MYOK | Buy Now | MyoKardia | — | — | $127 → $225 | Downgrade | Outperform → Neutral | Get Alert | |
| 09/01/2020 | FRLN | Buy Now | Freeline Therapeutics | — | — | → $28 | Initiates | → Outperform | Get Alert | |
| 08/18/2020 | INZY | Buy Now | Inozyme Pharma | — | — | → $35 | Initiates | → Outperform | Get Alert | |
| 08/13/2020 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $48 → $50 | Maintains | Outperform | Get Alert | |
| 08/06/2020 | GTHX | Buy Now | G1 Therapeutics | — | — | $50 → $46 | Maintains | Outperform | Get Alert | |
| 07/21/2020 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $25 | Initiates | → Outperform | Get Alert | |
| 07/07/2020 | UMRX | Buy Now | Unum Therapeutics | — | — | $1 → $4 | Upgrade | Neutral → Outperform | Get Alert | |
| 06/23/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $6.80 | 282.35% | $25 → $26 | Maintains | Neutral | Get Alert | |
| 05/13/2020 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | $45 → $48 | Maintains | Outperform | Get Alert | |
| 05/05/2020 | STML | Buy Now | Stemline Therapeutics | — | — | $11 → $12.5 | Downgrade | Outperform → Neutral | Get Alert | |
| 05/01/2020 | NVCR | Buy Now | NovoCure | $13.20 | 491.04% | $80 → $78 | Maintains | Neutral | Get Alert | |
| 04/03/2020 | FATE | Buy Now | Fate Therapeutics | $1.14 | 3512.33% | $38 → $41 | Maintains | Outperform | Get Alert | |
| 03/17/2020 | STML | Buy Now | Stemline Therapeutics | — | — | $14 → $11 | Maintains | Outperform | Get Alert | |
| 03/04/2020 | UMRX | Buy Now | Unum Therapeutics | — | — | $7 → $1 | Downgrade | Outperform → Neutral | Get Alert | |
| 03/02/2020 | BEAM | Buy Now | Beam Therapeutics | $27.55 | 16.15% | → $32 | Initiates | → Outperform | Get Alert | |
| 02/27/2020 | GTHX | Buy Now | G1 Therapeutics | — | — | $67 → $55 | Maintains | Outperform | Get Alert | |
| 02/14/2020 | FATE | Buy Now | Fate Therapeutics | $1.14 | 2807.49% | $29 → $33 | Maintains | Outperform | Get Alert | |
| 02/14/2020 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.06 | 107.99% | $71 → $75 | Maintains | Outperform | Get Alert | |
| 02/14/2020 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | 74.1% | $21 → $16 | Downgrade | Outperform → Neutral | Get Alert | |
| 01/24/2020 | EPZM | Buy Now | Epizyme | — | — | $24 → $30 | Maintains | Outperform | Get Alert | |
| 01/17/2020 | KPTI | Buy Now | Karyopharm Therapeutics | $6.80 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 01/17/2020 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 1799900% | → $9 | Downgrade | Outperform → Neutral | Get Alert | |
| 01/16/2020 | STML | Buy Now | Stemline Therapeutics | — | — | $17 → $14 | Maintains | Outperform | Get Alert | |
| 01/07/2020 | ISEE | Buy Now | IVERIC bio | — | — | → $13 | Initiates | → Outperform | Get Alert | |
| 12/03/2019 | BOLD | Buy Now | Audentes Therapeutics | $1.15 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 11/11/2019 | STML | Buy Now | Stemline Therapeutics | — | — | $20 → $17 | Maintains | Outperform | Get Alert | |
| 10/08/2019 | SWTX | Buy Now | SpringWorks Therapeutics | — | — | → $33 | Initiates | → Outperform | Get Alert | |
| 09/10/2019 | TPTX | Buy Now | Turning Point | — | — | → $63 | Initiates | → Outperform | Get Alert | |
| 08/08/2019 | MYOK | Buy Now | MyoKardia | — | — | $87 → $90 | Maintains | Outperform | Get Alert | |
| 08/02/2019 | ARGX | Buy Now | argenx | $851.59 | -80.04% | $144 → $170 | Maintains | Outperform | Get Alert | |
| 08/02/2019 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.06 | 107.99% | → $75 | Assumes | → Outperform | Get Alert | |
| 07/26/2019 | NVCR | Buy Now | NovoCure | $13.20 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 05/13/2019 | STML | Buy Now | Stemline Therapeutics | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 05/03/2019 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 05/03/2019 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 03/11/2019 | TCRR | Buy Now | TCR2 Therapeutics | — | — | → $28 | Initiates | → Outperform | Get Alert | |
| 03/01/2019 | ARGX | Buy Now | argenx | $851.59 | -83.09% | $131 → $144 | Maintains | Outperform | Get Alert | |
| 02/27/2019 | KPTI | Buy Now | Karyopharm Therapeutics | $6.80 | -11.76% | $14 → $6 | Maintains | Outperform | Get Alert | |
| 02/11/2019 | FATE | Buy Now | Fate Therapeutics | $1.14 | 1750.22% | $19 → $21 | Maintains | Outperform | Get Alert | |
| 12/07/2018 | XNCR | Buy Now | Xencor | $16.84 | 161.21% | $42 → $44 | Maintains | Outperform | Get Alert | |
| 12/04/2018 | ARGX | Buy Now | argenx | $851.59 | -84.62% | $130 → $131 | Maintains | Outperform | Get Alert | |
| 12/04/2018 | TSRO | Buy Now | Tesaro | — | — | $60 → $75 | Downgrade | Outperform → Neutral | Get Alert | |
| 11/09/2018 | KPTI | Buy Now | Karyopharm Therapeutics | $6.80 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 11/07/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | → $40 | Upgrade | Underperform → Neutral | Get Alert | |
| 11/05/2018 | ARGX | Buy Now | argenx | $851.59 | -84.73% | $125 → $130 | Maintains | Outperform | Get Alert | |
| 11/02/2018 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | 117.63% | $36 → $20 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/29/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.06 | 144.04% | $90 → $88 | Maintains | Outperform | Get Alert | |
| 10/22/2018 | STRO | Buy Now | Sutro Biopharma | $9.76 | 104.92% | → $20 | Initiates | → Outperform | Get Alert | |
| 10/08/2018 | BOLD | Buy Now | Audentes Therapeutics | $1.15 | 4441.48% | $49 → $52 | Maintains | Outperform | Get Alert | |
| 09/17/2018 | FENC | Buy Now | Fennec Pharmaceuticals | $7.76 | 106.19% | $17 → $16 | Maintains | Outperform | Get Alert | |
| 08/30/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.06 | 149.58% | $80 → $90 | Maintains | Outperform | Get Alert | |
| 08/14/2018 | UMRX | Buy Now | Unum Therapeutics | — | — | $18 → $20 | Maintains | Outperform | Get Alert | |
| 08/06/2018 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.06 | 121.85% | $71 → $80 | Maintains | Outperform | Get Alert | |
| 07/27/2018 | NVCR | Buy Now | NovoCure | $13.20 | 203.1% | $33 → $40 | Maintains | Outperform | Get Alert | |
| 07/16/2018 | ECYT | Buy Now | Endocyte | — | — | $15 → $21 | Maintains | Outperform | Get Alert | |
| 06/25/2018 | ARGX | Buy Now | argenx | $851.59 | -86.61% | $93 → $114 | Maintains | Outperform | Get Alert | |
| 05/29/2018 | STML | Buy Now | Stemline Therapeutics | — | — | $20 → $22 | Maintains | Outperform | Get Alert | |
| 05/24/2018 | KPTI | Buy Now | Karyopharm Therapeutics | $6.80 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 05/11/2018 | VYGR | Buy Now | Voyager Therapeutics | $4.37 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 04/27/2018 | NVCR | Buy Now | NovoCure | $13.20 | 150.06% | $29 → $33 | Maintains | Outperform | Get Alert | |
| 04/26/2018 | ARGX | Buy Now | argenx | $851.59 | -89.2% | $88 → $92 | Maintains | Outperform | Get Alert | |
| 04/24/2018 | EPZM | Buy Now | Epizyme | — | — | $24 → $20 | Maintains | Outperform | Get Alert | |
| 04/23/2018 | UMRX | Buy Now | Unum Therapeutics | — | — | → $18 | Initiates | → Outperform | Get Alert | |
| 04/16/2018 | BPMC | Buy Now | Blueprint Medicines | — | — | $98 → $106 | Maintains | Outperform | Get Alert | |
| 03/19/2018 | XNCR | Buy Now | Xencor | $16.84 | 131.52% | $38 → $39 | Maintains | Outperform | Get Alert | |
| 03/13/2018 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 2599900% | $11 → $13 | Maintains | Outperform | Get Alert | |
| 03/12/2018 | VYGR | Buy Now | Voyager Therapeutics | $4.37 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 03/12/2018 | FENC | Buy Now | Fennec Pharmaceuticals | $7.76 | 119.07% | → $17 | Initiates | → Outperform | Get Alert | |
| 03/06/2018 | FATE | Buy Now | Fate Therapeutics | $1.14 | 1574.01% | $10 → $19 | Maintains | Outperform | Get Alert | |
| 02/20/2018 | ANAB | Buy Now | AnaptysBio | $45.09 | 234.89% | $142 → $151 | Maintains | Outperform | Get Alert | |
| 01/16/2018 | ONCE | Buy Now | Spark Therapeutics | — | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 11/20/2017 | PRTA | Buy Now | Prothena Corp | $9.99 | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 10/03/2017 | ECYT | Buy Now | Endocyte | — | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 09/14/2017 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.06 | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 08/29/2017 | KITE | Buy Now | Kite Pharma | — | — | — | Upgrade | Underperform → Neutral | Get Alert | |
| 08/29/2017 | JUNO | Buy Now | Juno Therapeutics | — | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 08/28/2017 | CMTA | Buy Now | Clementia Pharmaceuticals Inc. - Common Shares | — | — | → $26 | Initiates | → Outperform | Get Alert | |
| 06/12/2017 | GTHX | Buy Now | G1 Therapeutics | — | — | → $31 | Initiates | → Outperform | Get Alert | |
| 06/05/2017 | ECYT | Buy Now | Endocyte | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 05/09/2017 | KITE | Buy Now | Kite Pharma | — | — | — | Downgrade | Neutral → Underperform | Get Alert | |
| 04/19/2017 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.06 | 107.99% | $80 → $75 | Downgrade | Outperform → Neutral | Get Alert | |
| 03/28/2017 | TSRO | Buy Now | Tesaro | — | — | $164 → $174 | Reiterates | → Outperform | Get Alert | |
| 03/23/2017 | RARE | Buy Now | Ultragenyx Pharmaceutical | $36.06 | 121.85% | $88 → $80 | Reiterates | → Outperform | Get Alert | |
| 03/15/2017 | TSRO | Buy Now | Tesaro | — | — | $200 → $164 | Reiterates | → Outperform | Get Alert | |
| 03/09/2017 | ANAB | Buy Now | AnaptysBio | $45.09 | -37.9% | → $28 | Reiterates | → Outperform | Get Alert | |
| 02/28/2017 | FATE | Buy Now | Fate Therapeutics | $1.14 | 516.74% | → $7 | Reiterates | → Outperform | Get Alert | |
| 02/21/2017 | ANAB | Buy Now | AnaptysBio | $45.09 | -37.9% | → $28 | Initiates | → Outperform | Get Alert | |
| 02/01/2017 | JUNO | Buy Now | Juno Therapeutics | — | — | → $24 | Initiates | → Neutral | Get Alert | |
| 01/27/2017 | NOVN | Buy Now | Novan | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 11/28/2016 | PNRA | Buy Now | Panera Bread | — | — | → $220 | Downgrade | Outperform → Neutral | Get Alert | |
| 10/17/2016 | NOVN | Buy Now | Novan | — | — | — | Initiates | → Outperform | Get Alert | |
| 09/20/2016 | WCIC | Buy Now | WCI Communities | — | — | → $21 | Initiates | → Neutral | Get Alert | |
| 09/12/2016 | VTAE | Buy Now | Vitae Pharmaceuticals | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 08/22/2016 | MDVN | Buy Now | Medivation | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 08/22/2016 | MDVN | Buy Now | Medivation | — | — | → $81.5 | Downgrade | Outperform → Neutral | Get Alert | |
| 08/18/2016 | CERU | Buy Now | Cerulean Pharma | — | — | $9 → $1 | Downgrade | Outperform → Neutral | Get Alert | |
| 08/16/2016 | PSG | Buy Now | Performance Sports Group | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 08/15/2016 | BOLD | Buy Now | Audentes Therapeutics | $1.15 | 1646.72% | → $20 | Initiates | → Outperform | Get Alert | |
| 07/25/2016 | OUTR | Buy Now | Space Acquisition Corp. I | — | — | → $45 | Downgrade | Buy → Neutral | Get Alert | |
| 07/25/2016 | SYRS | Buy Now | Syros Pharmaceuticals | $0.00 | 3599900% | → $18 | Initiates | → Outperform | Get Alert | |
| 07/15/2016 | STJ | Buy Now | St Jude Medical | — | — | $70 → $84 | Downgrade | Outperform → Neutral | Get Alert | |
| 06/16/2016 | RLYP | Buy Now | Relypsa | — | — | $51 → $51 | Maintains | Outperform | Get Alert | |
| 06/09/2016 | RLYP | Buy Now | Relypsa | — | — | → $51 | Maintains | Outperform | Get Alert | |
| 05/31/2016 | NTLA | Buy Now | Intellia Therapeutics | $9.19 | — | — | Initiates | → Outperform | Get Alert | |
| 05/11/2016 | EPRS | Buy Now | EPIRUS Biopharmaceuticals | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 03/30/2016 | ONCE | Buy Now | Spark Therapeutics | — | — | → $21 | Initiates | → Underperform | Get Alert | |
| 01/20/2016 | TSRO | Buy Now | Tesaro | — | — | → $72 | Initiates | → Outperform | Get Alert | |
| 11/23/2015 | MYOK | Buy Now | MyoKardia | — | — | → $22 | Initiates | → Outperform | Get Alert | |
| 10/27/2015 | NVCR | Buy Now | NovoCure | $13.20 | 127.32% | → $30 | Initiates | → Outperform | Get Alert | |
| 10/07/2014 | KPTI | Buy Now | Karyopharm Therapeutics | $6.80 | 635.29% | → $50 | Initiates | → Outperform | Get Alert | |
| 10/28/2013 | FATE | Buy Now | Fate Therapeutics | $1.14 | 1133.48% | → $14 | Initiates | → Outperform | Get Alert | |
| 10/25/2013 | PRTA | Buy Now | Prothena Corp | $9.99 | 220.16% | $18 → $32 | Maintains | Outperform | Get Alert | |
| 09/12/2013 | STML | Buy Now | Stemline Therapeutics | — | — | → $49 | Initiates | → Outperform | Get Alert | |
| 09/11/2013 | STML | Buy Now | Stemline Therapeutics | — | — | → $49 | Initiates | → Outperform | Get Alert | |
| 06/27/2013 | PRTA | Buy Now | Prothena Corp | $9.99 | 80.09% | → $18 | Initiates | → Outperform | Get Alert | |
| 06/27/2013 | EPZM | Buy Now | Epizyme | — | — | → $37 | Initiates | → Outperform | Get Alert | |
| 03/27/2013 | ECYT | Buy Now | Endocyte, Inc. | — | — | $16 → $20 | Maintains | Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved